Andrew Huberman· PhD
And it seems like, in pathogens like MDMA, in proper clinical settings, can help do that.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
And it seems like, in pathogens like MDMA, in proper clinical settings, can help do that.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
So, what I'm referring to here is, for instance, a lot of therapies, whether or not it's a cognitive behavioral therapy, or it's MDMA-assisted psychotherapy for PTSD, or whether or not it's just really trying to get more REM sleep each night so that you can unload the emotional weight of previous day experiences, which seems to be a hallmark of REM sleep...